Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Steakholder Foods has transitioned from R&D to commercialization in 2024. The company secured its first commercial revenues through strategic deals with partners such as Bondor Foods Ltd. and Wyler Farm. It continues to develop advanced 3D-printing technologies for producing plant-based meats and fish analogs that closely mimic traditional animal proteins. The firm anticipates substantial recurring revenue growth in 2025 as it expands its market presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Steakholder Foods.